Gervasini Cristina, Parenti Ilaria, Picinelli Chiara, Azzollini Jacopo, Masciadri Maura, Cereda Anna, Selicorni Angelo, Russo Silvia, Finelli Palma, Larizza Lidia
Medical Genetics, Department of Health Sciences, Università degli Studi di Milano, Via A. di Rudinì 8, 20142 Milan, Italy.
Eur J Med Genet. 2013 Mar;56(3):138-43. doi: 10.1016/j.ejmg.2012.12.009. Epub 2013 Jan 8.
Cornelia de Lange syndrome (CdLS, OMIM #122470, #300590, #610759, #614701, #300882) is a rare neurodevelopmental syndrome characterized by growth retardation, intellectual disability, dysmorphic facial features, multisystem malformations, and limb reduction defects. Wide variability of phenotypes is common among CdLS patients. Mutations in genes encoding either regulators (NIPBL, HDAC8) or subunits (SMC1A, SMC3, RAD21) of the cohesin complex, are altogether found in approximately 65% of CdLS patients. We describe a CdLS patient with classic severe phenotype who was found negative to mutations in the NIPBL and SMC1A genes by DHPLC and direct sequencing. MLPA analysis performed to disclose potential intragenic NIPBL deletions/duplications, suggested a partial deletion which was confirmed by FISH with a BAC clone encompassing the NIPBL region that highlighted asymmetric signals in a fraction of cells (72%). The occurrence of a genomic deletion in mosaic condition was validated by array-CGH analysis. Long-range PCR and sequencing of the junction fragment mapped the telomeric and the centromeric breakpoint within NIPBL IVS1 and IVS32, respectively. Both deletion breakpoints were embedded in a microsatellite region that might be the motif directly mediating this large deletion by an intrachromatid recombination mechanism. Consistent with the molecular analyses, the patient displayed a severe phenotype that was characterized by drastic CdLS clinical signs including premature death. This case provides a second example of mosaicism in CdLS. Despite mitigated by mosaicism, the large intragenic deletion identified in the present case was poorly tolerated due to the high mosaicism level. Based on these data, overlooked cases of mosaicism may lead to underestimated mutation rates of known genes and may also contribute to the clinical heterogeneity of CdLS.
科妮莉亚·德朗格综合征(CdLS,OMIM编号#122470、#300590、#610759、#614701、#300882)是一种罕见的神经发育综合征,其特征为生长发育迟缓、智力残疾、面部畸形、多系统畸形以及肢体减少缺陷。CdLS患者的表型差异很大。在大约65%的CdLS患者中,共发现编码黏连蛋白复合体调节因子(NIPBL、HDAC8)或亚基(SMC1A、SMC3、RAD21)的基因突变。我们描述了一名具有典型严重表型的CdLS患者,通过变性高效液相色谱(DHPLC)和直接测序发现其NIPBL和SMC1A基因无突变。为了揭示潜在的NIPBL基因内缺失/重复而进行的多重连接探针扩增(MLPA)分析提示存在部分缺失,用包含NIPBL区域的细菌人工染色体(BAC)克隆进行荧光原位杂交(FISH)证实了这一缺失,该克隆在一部分细胞(72%)中显示出不对称信号。通过比较基因组杂交芯片(array-CGH)分析验证了镶嵌状态下基因组缺失的存在。对连接片段进行长距离聚合酶链反应(PCR)和测序,分别将端粒和着丝粒断点定位在NIPBL的IVS1和IVS32内。两个缺失断点都位于一个微卫星区域内,该区域可能是通过染色单体内重组机制直接介导这种大片段缺失的基序。与分子分析结果一致,该患者表现出严重的表型,其特征为包括过早死亡在内的典型CdLS临床症状。该病例提供了CdLS镶嵌现象的第二个实例。尽管镶嵌现象减轻了影响,但由于镶嵌水平较高,本病例中鉴定出的大片段基因内缺失耐受性较差。基于这些数据,被忽视的镶嵌病例可能导致已知基因突变率被低估,也可能导致CdLS临床异质性增加。